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Parallel synthesis and splicing redirection activity of
cell-penetrating peptide conjugate libraries of a PNA
cargo†
Peter J. Deuss, Andrey A. Arzumanov, Donna L. Williams and Michael J. Gait*
A novel method for the parallel synthesis of peptide-biocargo conjugates was developed that utilizes
aﬃnity puriﬁcation for fast isolation of the conjugates in order to avoid time consuming HPLC puriﬁ-
cation. The methodology was applied to create two libraries of cell-penetrating peptide (CPP)–PNA705
conjugates from parallel-synthesized peptide libraries. The conjugates were tested for their ability to
induce splicing redirection in HeLa pLuc705 cells. The results demonstrate how the novel methodology
can be applied for screening purposes in order to ﬁnd suitable CPP-biocargo combinations and further
optimization of CPPs.
Introduction
Eﬃcient cell delivery of bio-molecules, such as oligonucleo-
tides and peptides, is a major hurdle in development of novel
therapeutics. As a result, higher drug dosages are often
required than would otherwise be needed, which increases
costs and the possibility of oﬀ target eﬀects. A promising
method of enhancing cell delivery is by use of cell-penetrating
peptides (CPPs) to facilitate cell-uptake.1 CPPs often contain
positive charges and/or hydrophobic elements. Some are
based on cell-permeable peptides obtained from larger pro-
teins and are known as protein transduction domains (PTD),
whereas others are synthetically derived. CPPs have been
shown to deliver a range of diﬀerent biologically active cargoes
into cells and in vivo, including proteins, peptides, oligo-
nucleotide analogues, siRNAs and small molecule drugs.2
In the case of oligonucleotide cargoes, CPPs can either
be complexed with or conjugated covalently to the cargo.
For example, CPP conjugates of charge neutral antisense
phosphorodiamidate morpholino oligonucleotides (PMO) or
peptide nucleic acids (PNA) have been shown to be very
eﬀective in induction of splicing redirection or exon skipping
in cells and in vivo.3 However, there have been very many CPPs
proposed, and individual research groups often utilise their
own preferred peptide sequences. No single CPP has been
found to be universally successful for the conjugate delivery of
all cargoes into all cell types. Instead for a new drug target
or application, success is often only achieved through pain-
staking conjugate synthesis on an individual basis and search for
a suitable peptide sequence by trial and error using a cell or
in vivo assay.
Only a small number of CPPs (commonly 2 or 3 known
CPPs) can usually be tested as bio-cargo conjugates because of
the diﬃculty and the time-consuming nature of their syn-
theses, even though cell-screening reporter assays, e.g. luciferase-
based, are frequently available and adaptable for high-through-
put. Significant demand exists therefore for a method of
peptide conjugate library synthesis that is quick and eﬃcient
and is suitable for subsequent use of rapid screening assays.4
Following cell assay of an initial library of conjugates using
peptides of widely ranging sequence, fine-tuning of a peptide
candidate can then be accomplished either by further
narrower library synthesis and cell re-assay, or by more conven-
tional synthesis if further screening is to be carried out by an
in vivo assay.
The most time-limiting step in synthesis of peptide-cargo
conjugates is generally not the conjugation itself but the indi-
vidual purifications required for peptide, cargo and conjugate.
Recently, parallel multi-peptide synthesis machines have
become available as well as new methods for rapid aﬃnity-
based purification of bio-molecules (e.g. histidine tags or
biotin-streptavidin)4b that provide an opportunity both for
rapid synthesis and for reaction workup and purification.
In addition, recent developments in bio-orthogonal “click”-
type ligation reactions provide a chemical basis for eﬃcient
†Electronic supplementary information (ESI) available: MALDI mass-
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acid sequences, purity, synthesis and conjugation yields of LB2. Examples of
HPLC-graphs and MALDI mass-spectra for peptides and conjugates. Luciferase
readout of LB1 crude and purified PNA705 conjugates and single data-point
splice correction assay of LB2–PNA705 conjugates. See DOI: 10.1039/c3ob41659c
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conjugation of bio-molecules in aqueous solution.5 These new
methodologies have now inspired us to develop a new strategy
for the SELection of PEPtide CONjugates (SELPEPCON) of bio-
cargoes that can act as an initial parallel synthesis approach
useful for therapeutic screening.
SELPEPCON allows for convenient and rapid parallel conju-
gation reactions and workup that avoid the need for HPLC
purification (Fig. 1). The method utilizes a functionalized
cargo linked through a cleavable linker to an aﬃnity tag. The
functionalized cargo is conjugated to the peptide after which it
is purified by immobilization and isolated by release of the
tag. Aﬃnity purification is very rapid and is readily automated,
making the overall strategy very suitable for high-throughput
synthesis of conjugates for screening.
To demonstrate the utility of this SELPEPCON method-
ology, two case studies are shown. In the first example, a small
conjugate library is synthesized to investigate the roles of indi-
vidual or groups of amino acids in a pre-selected CPP attached
to a cargo. The second shows a larger CPP screen of a variety
of quite diﬀerent peptide sequences to find CPP candidates
suitable for delivery of a novel cargo into a cell. Both studies
utilize CPP conjugates of a PNA705 cargo, a well-known 16-mer
splice-redirecting oligonucleotide analogue cargo that has
been used many times for CPP development in the past.6 A
HeLa pLuc705 cell assay was employed to assess the construct
for their ability to enter cells. In this assay, PNA705, upon
entering the cell, causes splicing redirection of an aberrant
β-globin intron, which leads to the up-regulation of firefly luci-
ferase.7 The assay is convenient, has a high dynamic range
and is very suitable for testing of a large number of conjugates
in parallel.
Conjugations are carried out using copper catalyzed
Huisgen “click” reactions8 between alkyne-functionalized CPPs
and an azide-functionalized PNA705 containing a disulphide-
linked biotin-tag. The disulphide-linked biotin tag allows for
solid-phase immobilization purification of the resultant conju-
gates after which the conjugates can be isolated by reduction
of the disulphide releasing it from the solid support. The
results demonstrate how SELPEPCON can be utilized to find
active CPPs for a cargo such as PNA705 in a rapid synthesis,
isolation and screening procedure.
Results and discussion
Cargo synthesis
The SELPEPCON method of synthesis of a bifunctionalized
PNA705 cargo suitable for attachment of peptides and sub-
sequent immobilization is shown in Scheme 1. Because a
known side product of the click reaction is alkyne homocou-
pling, we decided to locate the azide functionality on the PNA
cargo and the alkyne functionality on the peptide component.
In this setup any alkyne-homocoupling side reaction will lead
to a product that is easily removed by washing of the strepta-
vidin solid support. Thus, 5-azidopentanoic acid was used for
N-terminal modification of the PNA by manual solid phase
amide coupling following machine-aided assembly of the PNA
by solid-phase synthesis.9
The PNA contains a C-terminal S-trityl-protected Cys
residue, which was introduced at the first step of solid-phase
synthesis. After deprotection and cleavage from the solid
support, a biotin group was introduced on to the N3-PNA705
Fig. 1 Overview of conjugation and conjugate work-up strategy of SELPEPCON.
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by disulfide bridge formation via reaction of the C-terminal
Cys residue with commercially available N-[6-(biotinamido)-
hexyl]-3′-(2′-pyridyldithio)propionamide (EZ-link™ HPDP
Biotin). This straight forward reaction provided the N3-PNA
(705)-S-S-biotin after HPLC purification in 80% yield.
Pip5h based CPP-library (LB1)
In order to demonstrate the methodology, a small test library
of 16 peptides was synthesized on Tentagel using an Intavis
Parallel Peptide Synthesizer (Table 1). The test library was nar-
rowly based around a known relatively short (17 amino acids)
CPP, Pip5h, which we have previously evaluated in exon skip-
ping as a conjugate with a PMO targeting the pre-mRNA of dys-
trophin,10 but which was not chosen for further development.
Peptide variants included modifications in the central 5-amino
acid core (LB1_1–8) or on one of the Arg-rich flanking regions
(LB1_9–16) of the sequences. In each case an N-terminal
alkyne was introduced using 4-pentynoic acid through stan-
dard amide bond formation as the final coupling step
(Scheme 2).
The peptides were deprotected and cleaved from the solid
support by standard TFA treatment for 4 h with gentle mixing
and rapidly isolated by solid phase extraction (SPE) using
Oasis HLB cartridges. Good yields were achieved using this
synthesis and purification method (Table 1). MALDI-TOF mass-
spectrometry of the products showed in all cases a major signal
corresponding to the expected peptide and only minor
amounts of peptide impurities (ESI Table S1 and Fig. S1, S2
and S13, S14†). None of the observed shorter peptide impuri-
ties should form conjugates in the subsequent conjugation
step because the alkyne linker is introduced in the final step
of the synthesis and truncated peptides are capped after each
coupling step during solid phase synthesis. Thus, time-
consuming HPLC purification of each synthesized peptide is
avoided. The peptide purification method used is fast, such
that cleavage, deprotection and purification of 16 peptides can
be carried out within one day, thus allowing for easy
parallelization.
LB1–PNA705 conjugate library synthesis
Peptide-PNA conjugates were synthesized, purified and iso-
lated in parallel using the procedure shown in Scheme 3.
Copper(II) sulphate in combination with sodium ascorbate proved
to be the most promising catalyst system. Procedures involving
copper(I) salts, such as copper(I) bromide or copper(I) iodide,
were also tested but provided less reproducible conversions.
Diisopropylethylamine was used as base to quench TFA salts
of the cargo and peptides, and 2,6-lutidine and tris(benzyltri-
azolylmethyl)amine (TBTA) were utilized to stabilize the active
copper(I) species. After 1 h, reactions were quenched by the
addition of EDTA, diluted and immobilized on a streptavidin-
functionalized Sepharose™-support held in SpinTrap™ centri-
fuge tubes. Following several washing steps, the conjugates
were released from the support by addition of a TBS buﬀer
Scheme 1 Synthesis of N3-PNA705-S-S-biotin cargo for conjugation to CPP-libraries.
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solution containing 10 mM tris(2-carboxyethyl)phosphine
(TCEP) followed by centrifugation, leaving the biotin tag on
the support. The use of organic solvent (e.g. 40% acetonitrile)
for dilution of the reaction mixtures, washing and release
proved to be essential for good recovery of the conjugates.
The resultant conjugates still contained buﬀer and TCEP,
which were removed by SPE using Oasis HLB cartridges.
The conjugates were obtained in good isolated yields
(50–70%, Table 1). In all cases, analysis by MALDI-TOF
mass-spectrometry showed the expected signal for the conju-
gation product (ESI Table S1 and Fig. S15–S17†). In addition, a
signal corresponding to the unconjugated PNA705 was
observed. Quantitative analysis by RP-HPLC revealed <10% of
the unconjugated cargo. As the cargo by itself is unable to
enter cells eﬃciently and has been demonstrated to be inactive
in the HeLa pLuc705 cell splicing redirection assay (data not
Table 1 Library of Pip5h analogues containing an N-terminal alkyne linker, peptide and conjugate synthesis yield







LB1_1 RXRRXRILFQYRXRRXR +8 8 2.7 (54) 21.0 (70)
LB1_2 RXRRXRYQFLIRXRRXR +8 8 3.0 (59) 21.0 (70)
LB1_3 RXRRXRFLQIYRXRRXR +8 8 2.6 (51) 21.4 (71)
LB1_4 RXRRXRAAAAARXRRXR +8 8 3.0 (59) 17.1 (57)
LB1_5 RXRRXRIKFQYRXRRXR +9 8 2.9 (58) 19.6 (65)
LB1_6 RXRRXRIEFQYRXRRXR +7 8 3.7 (73) 18.3 (61)
LB1_7 RXRRXRIWFQYRXRRXR +8 8 2.6 (51) 20.9 (70)
LB1_8 RXRRXRIPFQYRXRRXR +8 8 4.0 (79) 17.4 (58)
LB1_9 KXRKXRILFQYKXRKXR +8 4 3.4 (68) 18.4 (61)
LB1_10 HXRHXRILFQYHXRHXR +4 4 1.7 (35) 19.5 (65)
LB1_11 SXRSXRILFQYSXRSXR +4 4 3.2 (64) 17.3 (58)
LB1_12 EXREXRILFQYEXREXR 0 4 2.0 (40) 18.4 (61)
LB1_13 RMKWKKILFQYRXRRXR +8 5 1.7 (34) 18.8 (63)
LB1_14 RXRRXRILFQYRMKWKK +8 5 2.8 (56) 18.0 (60)
LB1_15 KKWKMRILFQYRXRRXR +8 5 1.5 (31) 18.2 (61)
LB1_16 RXRRXRILFQYKKWKMR +8 5 2.8 (56) 19.2 (64)
a All peptides contain a C-terminal amide and a 4-pentynoic acid group coupled to the N-terminus. bCrude yield from a 5 µmol synthesis after
Oasis HLB cartridge workup. Based on crude weight and corrected for TFA salts. c Yield of the LB1-PNA705 conjugate obtained via SELPEPCON
(Schemes 1–3) from a 30 nmol scale synthesis based on N3-PNA705-S-S-biotin, determined by UV absorption at 260 nm.
Scheme 2 Synthesis of alkyne functionalized peptides for conjugation to N3-PNA705-S-S-biotin.
Scheme 3 Outline of conjugation and puriﬁcation strategy to obtain CPP–
PNA705 conjugate libraries.
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shown), the conjugates containing small amounts of unconju-
gated PNA705 were used without further purification.
Compared to standard methods of preparing CPP–PNA con-
jugates, SELPEPCON is very fast and convenient. For a library
of 16 conjugates, parallel peptide synthesis and purification
took 3 days and conjugation and purification took only two
days including lyophilisation time. Thus, conjugates were
available within a week and enough peptide remains for many
more conjugation reactions. By contrast 16 individual conju-
gate syntheses, RP-HPLC purifications for each peptide, and
subsequent conjugations as well as conjugate desalting would
take a minimum of 48 hours each, excluding method
optimization.
Splicing redirection activity of LB1–PNA705 conjugate library
The PNA705 conjugates of LB1 were assessed for their ability
to enter HeLa pLuc705 cells and redirect splicing, resulting in
up-regulation of luciferase expression. Attempts were made to
use 96-well plates, instead of the commonly used 24-well
plates, to allow for faster screening. However, the obtained
results were hard to interpret because of large inconsistencies
in luminescence values. More reliable and reproducible results
were obtained with 48-well plates, which were used for all
screening assays shown in this work. Several conjugates were
purified by RP-HPLC and assayed, which provided similar
results compared to the crude conjugates obtained by SELPEP-
CON (ESI Fig. S30†).
The full LB1–PNA705 conjugate library was assayed at a
single-concentration (5 µM) and the results analysed as the
fold increase in luminescence compared to buﬀer only (Fig. 2).
Several of the LB1–PNA705 constructs were strongly active, as
was expected for Arg-rich peptides. Substantial reduction in
the number of Arg residues (e.g. multiple replacements by His,
Ser or Glu) led to significantly lower activity (LB1_10–12).
When the Arg residues were replaced by Lys, retaining the
overall positive charge, some splicing redirection activity was
retained (LB1_9 and 13–16). LB1–PNA705 conjugates diﬀer
slightly from CPP–PNA constructs previously synthesized by
us.6,10 Thus, LB1–PNA conjugates contain an additional free
Cys residue and the peptide to PNA conjugation is N- to N-ter-
minus rather than C- to N-terminal conjugation used in pre-
vious work. However, LB1_1 containing the original Pip5h
sequence showed similar splicing redirection activity to that of
previously synthesised Pip5h-PNA705 (data not shown).
Amongst the more active conjugates, variations in splicing
redirection activity observed in the HeLa cells were not identi-
cal to those that might have been expected based on knowl-
edge of exon skipping eﬀects in mouse mdx muscle cells for
which the Pip5 and the later Pip6 series were designed.10,11
Scrambling of the hydrophobic core (LB1_3), replacement by
Ala residues (LB1_4), substitution of Leu by Pro (LB1_8) or a
negatively charged Glu (LB1_6) all appeared to be detrimental
to the activity (Fig. 2). Good splicing redirection activity
was retained by reversal of the core sequence (LB1_2) or by
replacement of a Leu by a Trp (LB1_7). The latter gives an
IWFQ sequence also found in Penetratin, from which the
hydrophobic core sequence of the Pip series was originally
derived. Interestingly, the replacement of same Leu by a Lys
residue significantly increased activity (LB1_5).
The results of CPP–PNA705 conjugate library based on LB1
demonstrate how SELPEPCON can be eﬀective for study and
optimization of the amino acid sequence of a CPP for delivery
of a cargo into a particular cell system providing that a cellular
assay is available.
Parallel synthesis and purification of LB2 CPP-library
We now wished to apply the SELPEPCON methodology to a sig-
nificantly larger library in order to demonstrate its potential
for selection of a CPP from a large range of sequence-dissimi-
lar peptides, which would be necessary in the case of a new
cargo candidate where relatively little was known about likely
requirements for intracellular activity. Thus we designed
peptide library LB2 consisting of 78 peptides that included
many well-known CPPs, some sequences obtained from
searching scientific literature, and some newly designed
(Table S2, ESI†). The peptides in this library consisted of both
hydrophobic and hydrophilic peptides, ranged in length from
6–28 amino acids and carried a net charge ranging from −1 to
+13. The library consisted of standard L-amino acids with the
addition of β-alanine (B) and ε-aminocaproic acid (X), which
are commonly found in CPPs.2b,c
Since it was found that free thiol groups inhibited the
copper-catalysed cycloaddition reaction, Cys residues could
not be introduced using Cys(Trt), which is the standard pro-
tecting group used in peptide synthesis. Instead an alternative
procedure was developed using S-tert-butylthio (StBu) protected
L-cysteine, which contains a disulfide-protecting group that is
Fig. 2 Fold increase in luminescence caused by PNA705 conjugates of LB1-
peptides compared to a buﬀer blank induced by the conversion of Beetle luci-
ferin to oxyluciferin by expressed luciferase via splicing redirection in HeLa
pLuc705 cells at 5 µM conjugate concentration.
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stable to TFA cleavage but which is released in the reducing
step of the conjugate workup procedure.
The library of CPPs (LB2) was synthesised in parallel using
the procedure described above for LB1. Only standard syn-
thesis protocols were used for the parallel synthesizer and a
single method for purification and isolation was employed
without any peptide specific optimization. Using these stan-
dard conditions, all but 5 of the 78 peptides (>90%) were suc-
cessfully obtained, where the expected masses were seen as
main signals in mass spectrometry (ESI Tables S2, S3 and
Fig. S3–S12†). Because of the type of work-up procedure, small
amounts of impurities were seen in most of the mass-spectra
obtained for the successfully synthesised peptides. In 4 peptide
syntheses a significant amount of shorter acetyl-capped peptide
sequences was observed, which is the result of incomplete
coupling reactions (Fig. S11 and S12†). Overall yields for the
73 successful syntheses were good (±70% average) and provided
plenty of peptide material in principle for many diﬀerent
conjugation reactions on nanomole scale for this CPP library.
Since 20 peptides could be purified easily in parallel, the
library was obtained in a total of only 9 days, including time
for automated peptide assembly. Further parallelization to
allow for the purification of more peptides simultaneously
should lead to further decreases in this time.
LB2–PNA705 conjugate library synthesis
The LB2 peptides were conjugated to PNA705 using the pro-
cedure described previously for LB1 conjugations. Most conju-
gates were obtained in good yield (>60% average, ESI Tables S2
and S3†). As in the case of LB1, a small amount of unconju-
gated PNA was observed by MALDI-TOF mass-spectroscopy and
HPLC for all conjugates obtained (ESI Fig. S18–S29†). Out of
the 73 peptides where there was a peptide product available
for conjugation, 10 conjugates were either not obtained or
showed only small amounts of conjugate product compared to
unconjugated PNA following aﬃnity purification and desalt-
ing. The failed conjugations were practically all for the longer
peptides that are likely to be more prone to form secondary
structures, which may sterically inhibit the conjugation
reactions.
In the cases of all 4 peptides (vide supra) that showed sig-
nificant amounts of acetyl-capped peptide impurities, good
quality conjugate products were nevertheless obtained. This
demonstrates the eﬀectiveness of the introduction of the
alkyne linker in the final step of assembly in combination with
acetic anhydride capping after each synthesis cycle during
peptide synthesis, which allows for the removal of these
peptide-impurities during aﬃnity purification of the
conjugates.
The four LB2–PNA705 conjugates that contained Cys resi-
dues (see Table S3, ESI†) showed by mass-spectrometry
impurities that resulted from a statistical mixture of StBu
modifications. Some modification was even observed of the
Cys residue that remains attached to PNA705 after release
from the aﬃnity support, which was evidenced by the fact that
conjugate masses were found corresponding to two StBu
groups for conjugates that contained only one Cys residue in
the peptide part. This may be because residual free StBu that
is not eﬀectively removed by the Oasis HLB cartridge workup
of the conjugates can slowly allow StBu disulfides to form with
available Cys residues in the conjugates. The StBu disulfide
protecting groups are clearly cleaved oﬀ during the reduction
step in SELPEPCON, since the alternative use of centrifugal
filter units (Amicon Ultra 3 K 0.5 mL, Millipore Ireland Ltd) to
remove salts, TCEP reducing agent and StBu did provide the
main product conjugates without StBu modifications.
However, this procedure resulted in low yields, especially for
hydrophobic conjugates.
Once again the synthesis and purification procedures were
very fast and eﬀective. In addition to the good yields of the
large majority of the conjugates, the conjugations and purifi-
cations involved in the whole library could be carried out
within 8 days.
Splicing redirection activity of LB2–PNA705 conjugate library
The LB2–PNA705 conjugate library was screened at 5 µM con-
centration for their ability to enter HeLa pLuc705 cells and
redirect splicing, resulting in up-regulation of luciferase
expression (Fig. 3). A significant number of active conjugates
were identified from this initial screen, showing 20- to 200-
fold increases in luminescence values. In some cases, high
error-bars were observed for conjugates that showed over a 20-
fold increase, because conjugates could not all be tested in a
single 48-well plate experiment and samples with high lumi-
nescence readouts show large variability between diﬀerent
experiments. However, the main purpose of the luciferase
readout is to distinguish active from inactive conjugates.
As a check on the reliability of purifications of conjugates
several conjugates were purified by HPLC and tested for their
ability to up-regulate luciferase expression (Fig. 4). None of the
tested low-activity crude conjugates showed significantly
higher activity after purification, revealing good reliability of
the crude conjugates in this assay. The mildly active PNA705
conjugate of LB2_21 does show improved activity after purifi-
cation. This can be explained because the crude conjugates
contain a small amount (±10%) of unconjugated PNA, lower-
ing the eﬀective concentration of the LB2_21–PNA705. This
highlights once again that the assay results using this crude
library should only be used to find suitable active CPP-candi-
dates for further investigation and active conjugates should
not be directly compared.
Some interesting observations can be inferred from the
results of the luciferase expression readouts. First, strong spli-
cing redirection for the PNA705 cargo in this HeLa-cell assay is
clearly directly related to the numbers of positive charges, par-
ticularly Arg residues, in the peptide part of the conjugates
(Fig. 5a and 5b). A charge of at least +8 and at least 7–8 argi-
nines are revealed as good CPPs properties. Association
between the number of Arg residues and cell penetrating
ability for CPP conjugates of PNA and PMO cargoes is well
known from previous literature,12 but never before has such a
large number and variety of CPPs of varying Arg content been
Paper Organic & Biomolecular Chemistry






















































































tested in parallel. Interestingly several standard CPP sequences
previously proposed for conjugation to PNA/PMO cargoes were
found to be ineﬀective in this assay (for example, two contain-
ing Tat sequences LB2_30 and 52, and two containing Penetra-
tin sequences LB2_28 and 35). These results show that
eﬀective cell penetration is cargo and cell dependent and
demonstrates how SELPEPCON can be a valuable tool in the
Fig. 3 Fold increase in luminescence caused by PNA705 conjugates of LB2-peptides compared to a buﬀer blank induced by the conversion of Beetle luciferin into
oxyluciferin by expressed luciferase via splicing redirection in HeLa pLuc705 cells at 5 µM conjugate concentration.
Fig. 4 Fold increase in luminescence caused by PNA705 conjugates of LB2-
peptides obtained by SELPEPCON (Crude) and RP-HPLC puriﬁed (Puriﬁed) com-
pared to a buﬀer blank induced by the conversion of Beetle luciferin into oxy-
luciferin by expressed luciferase via splicing redirection in HeLa pLuc705 cells at
5 µM conjugate concentration.
Fig. 5 Fold increase in luminescence as a function of (a) the net charge and (b)
the number of arginines of the CPPs in the LB2–PNA705 conjugates compared
to a buﬀer blank induced by the conversion of Beetle luciferin into oxyluciferin
by expressed luciferase via splicing redirection in HeLa pLuc705 cells at 5 µM
conjugate concentration. The dots represent the data points and the line
represents the average.
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selection of a good CPP candidate for a particular application.
An additional experiment was carried out in which all conju-
gates were evaluated in a single point assay to demonstrate
how a first round of selection can be performed after a
minimal screening eﬀort (ESI Fig. S31†). Although several
active conjugates give very high activity spikes, the same trend
for active conjugates is observed as for the multiple data-point
screening shown in Fig. 3.
A follow-up to screening can provide further information on
selected candidate conjugates. For example, initial “hits” can
be confirmed by evaluation of splicing redirection at the
RNA level.6 This assay is more reliable compared to the
luciferase readout but is less suitable in a high-throughput
mode because of the need for gel electrophoresis to separate
and quantify DNA strands. An example is shown in Fig. 6 in
which several LB2–PNA705 conjugates were assessed by extrac-
tion of RNA from the treated HeLa pLuc705 cells followed by
RT-PCR. Previously reported Pip-1-PNA,6 prepared by conven-
tional conjugation through a C- to N-terminal disulfide
linkage, was used as a positive control. As expected, the splice
corrected RNA levels were low when cells were exposed to
LB_54–PNA705, which also shows very low activity in the luci-
ferase readout. LB2_7 contains the same Pip1 sequence as the
positive control. The PNA705 conjugate was N- to N-terminally
linked as obtained through SELPEPCON and showed high
splice correction activity at both 2.5 and 5 µM. At 5 µM fully
spliced RNA levels are high for the PNA705 conjugates of
LB2_30–PNA705, 36 and 59, while LB2_30 showed significantly
lower luciferase activity. The saturation of the splicing redirec-
tion observed at 5 µM can explain the large variation in the
luciferase activity assay. At 2.5 µM these conjugates show the
same activity trend by RT-PCR as seen in the luciferase
readout obtained at 5 µM, highlighting the diﬀerence in sensi-
tivity between the two methods.
SELPEPCON assessment and application prospects
The SELPEPCON methodology described above has been
exemplified by use of libraries of CPPs conjugated to a PNA705
cargo where a reliable cell assay is available to gauge the eﬀec-
tiveness of the peptides in delivering the cargo into the
nucleus of HeLa cells. Clearly the methodology is in principle
applicable to any bio-cargo capable of being functionalized by
an azido group, such as PMO or other oligonucleotide types,
siRNA, peptides or other biomolecules where there is a need to
search for peptides that when conjugated to a cargo may
enhance its delivery into cells or for cell or tissue targeting.
For example, we are currently applying the SELPEPCON tech-
nology to cell delivery of a potential anti-cancer peptide known
to poorly enter cells itself. The only limitation is that the con-
structs need to be compatible with the conjugation step. For
example, a conjugation can fail for longer peptide sequences
that contain strong secondary structures, as shown for several
peptides in the LB2 library. This might be overcome by further
optimizing the conjugation conditions, such as use of a dena-
turing agent in the conjugation step.
We chose to conjugate the N-terminus of peptides to the
N-terminus of the cargo, since N-terminal peptide functionali-
zation is technically easier and in addition capping of
unreacted chains during synthesis reduces the possibility of
shorter chain peptide impurities becoming conjugated to the
cargo. Thus, 4 less pure peptides could nevertheless be conju-
gated to the PNA cargo and still lead to an acceptable
conjugate product. However, the method is not limited to
N-terminal conjugation via a N-terminal alkyne. To demonstrate
this we synthesized two peptides based on LB1_1 containing a
C-terminal alkyne (LB1_17 and LB1_18, Tables S4 and S5†).
The alkyne was placed on the C-terminus by using N-Fmoc-L-
bishomopropargylglycine-OH (Fmoc-Bpg-OH, Chiralix, Nijme-
gen, The Netherlands) during automated synthesis. Both pep-
tides were obtained in good yield. The double glycine spacer of
LB1_18 did not appear to be necessary to improve the conver-
sion of the conjugation reaction, as both conjugates were
readily obtained in good yield and purity. Note that it should
also be possible to achieve conjugation at the C-terminus of
PNA by use of an azido side-chain derivative of an Fmoc
amino acid (such as Fmoc-L-azido-lysine) at the C-terminus
and a Cys attached at the N-terminus of the PNA.
Following initial selection and verification of hits by the
SELPEPCON methodology using a wide CPP library, such as
LB2 described above, lead optimization would likely involve
further rounds of SELPEPCON screening using narrower
peptide libraries, as exemplified in LB1. Because the peptides
in LB1 are relatively similar, conjugation eﬃciency and thus
eﬀective concentration and purity of the conjugates obtained
by SELPEPCON will be less variable compared to a broad
library such as LB2.
The resultant libraries are also suitable for other screening
purposes such as comparisons of serum stabilities of the con-
jugates, if in vivo studies are to be contemplated. Once one or
more candidate peptides have been chosen for the desired
cargo, thereafter drug development might consist of investi-
gation of alternative conjugation methods to vary the type of
linkage between peptide and cargo, as well in some cases their
respective orientations to each other. Commonly such studies
are best carried out in an in vivo model of a disease state
using conjugates prepared more conventionally on larger
scale,6,9,12a,13 since pharmacological properties of conjugates
may vary substantially depending on cargo type as well as on
peptide sequence. It is possible that SELPEPCON could be
Fig. 6 RT-PCR analysis to measure aberrant and redirected RNA levels in HeLa
pLuc705 cells after exposure to CPP–PNA705 conjugates at diﬀerent concen-
trations. The activity is presented as a percentage of corrected RT-PCR product
obtained from splicing redirection.
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used for preparing conjugates for assay by intramuscular injec-
tion (e.g. into a mouse mdx model of Duchenne muscular dys-
trophy8) where only µg quantities are needed. However, use of
SELPEPCON should reduce considerably the time and eﬀort
required to obtain potential leads that are demonstrated to be
capable of the required biological eﬀect in a cell model,
hitherto a major bottleneck.
Experimental
General
MALDI-TOF mass spectrometry was carried out using a
Voyager DE Pro BioSpectrometry workstation. A stock solution
of 10 mg mL−1 of α-cyano-4-hydroxycinnamic acid in 60%
acetonitrile in water was used as matrix. Error bars are ±0.1%.
Reversed phase HPLC purifications and analyses were carried
out using a Varian 940-LC. A Nanodrop 2000 UV analyser
(Thermo Scientific) was used for the quantification of PNA
concentrations using the absorption at 260 nm with the follow-
ing values to calculate absorption coeﬃcients; C 6.6 cm−1 M−1,
T 8.6 cm−1 M−1, A 13.7 cm−1 M−1, G 11.7 cm−1 M−1. TBTA
(tris-(benzyltriazolylmethyl)amine) was synthesised according
to a literature procedure.14 The synthesis of the Pip-1-PNA705
conjugate had been reported previously.6,13b
N3-PNA705-SH synthesis
The PNA705 sequence containing a C-terminal Cys and two
flanking Lys residues (Lys-CCTCTTACCTCAGTTACA-Lys-Cys)
was synthesised on a 50 µmol scale using a modified Liberty
Peptide Synthesizer (CEM) according to a published procedure
[10] using a Chem-Matrix solid support and Fmoc amino acid
monomers (Novabiochem) or Fmoc (Bhoc) PNA monomers
(PolyOrg Inc.). After the final deprotection, the support was
removed from the synthesizer and 5-azidopentanoic acid was
manually double coupled using a standard PyBop/NMM coup-
ling reaction at room temperature for 2 × 15 min. The PNA was
cleaved from the support and deprotected using TFA (1.5 mL)
containing 10% triisopropylsilane/2.5% water and 1% phenol.
The mixture was agitated for 2 h after which it was filtered and
concentrated. The crude PNA was isolated by cold diethyl ether
precipitation, dissolved in water, filtered and purified by
HPLC. A Phenomenex Prep C18 Jupiter column (250 ×
21.2 mm, 10 micron) was used with the following gradient
(A: 0.1% TFA, B: 90% acetonitrile, 0.1% TFA) 0–2 min 7.5% B
2–20 min 7.5%–25% B 20–25 min 25%–90% B (retention time:
20.4 min). The fractions containing the desired PNA were com-
bined and freeze-dried giving a fluﬀy white solid (yield
10–40% based on support loading). Mass, expected: m/z 5250.0
found: m/z 5256.9.
N3-PNA705-S-S-biotin construct
To a solution of 4 µmol PNA705 in 3 mL water, was added 8 µmol
EZ-link HPDP-Biotin (Thermo Scientific) from a 3.7 µmol mL−1
stock in DMSO. To this solution 600 µl 2 M sodium
acetate pH 7 was added and the resulting solution shaken for
two hours. The reaction was quenched by the addition of
15 mL 0.1% TFA and 150 µl TFA in order to solubilise the pre-
cipitate formed. This solution was filtered and then purified
by HPLC using a Phenomenex Prep C18 Jupiter reversed phase
column (250 × 21.20 mm, 10 micron) with a the following gra-
dient (A: 0.1% TFA, B: 90% MeCN 0.1% TFA) 0–2 min 12% B
2–25 min 12%–25% B 25–30 min 25%–90% (retention time:
25.0 min). The purified N3-PNA-705-S-S-biotin was obtained as
a fluﬀy white powder in a typical yield of 60–80%. Mass,
expected: m/z 5678.4 found: m/z 5687.1.
Peptide synthesis
Peptide library synthesis was carried out on a 5 µmol scale
using an Intavis Parallel Peptide Synthesizer, applying stan-
dard Fmoc chemistry and following manufacturer’s rec-
ommendations. The solid support was as supplied by Intavis
(Tentagel, 0.2 mmol g−1). Double coupling steps were used
with a PyBop/NMM coupling mixture followed by acetic anhy-
dride capping after each coupling step. Terminal alkyne
functionalization involved a standard coupling procedure
using 4-pentynoic acid in the final step of the synthesis. The
peptides were cleaved from the support and deprotected by
addition of TFA (1.5 mL) containing 5% triisopropylsilane/
2.5% water and 1% phenol with shaking for 4 h. The support
suspension was then concentrated to a volume of ±500 µl
using a flow of nitrogen and diluted with 5 mL water. After
mixing, the resulting mixture was loaded on a 20 cc Oasis HLB
cartridge (Waters), which was previously washed with aceto-
nitrile (10 mL) and equilibrated with 0.1% TFA (3 × 10 mL).
After loading, the cartridge was washed with 0.1% TFA
(2 × 10 mL) and 5% acetonitrile in 0.1% TFA (2 × 10 mL).
The peptide was eluted with 40% acetonitrile (10 mL).
The solution obtained was freeze-dried and the yield was cal-
culated using the weight obtained (Table 1), corrected for the
amount of TFA salts based on the number of positive charges
present in the peptide. For mass spectroscopy data see
Tables S1 and S2.†
Conjugate synthesis
A mixture was prepared containing 30 nmol PNA from a stock
solution in water (±2 mM), 150 nmol peptide from a stock
solution in NMP (±10 mM), 0.2 µl 2,6-lutidine (1.7 µmol) and
1 µl diisopropylethylamine (5.7 µmol). 7.5 µl of 20 mM CuSO4–
TBTA solution (150 nmol) premixed in a 1 : 1 mixture of
DMSO/water and 10 µl of a 20 mM solution of sodium ascorbate
(200 nmol) were added to this mixture. The mixture was left for
one hour and quenched with 100 µl 0.2 M EDTA 40% aceto-
nitrile and 800 µl TBS 40% acetonitrile. The solution obtained
was vortexed and loaded in two batches of 500 µl on a strepta-
vidin HP SpinTrap (GE Healthcare UK Limited) and each batch
was incubated for 20 minutes while being mixed by inversion.
The column was washed with 400 µl 0.1 M EDTA in TBS 40%
acetonitrile and with 5 × 400 µl TBS 40% MeCN. The conjugate
was released from the resin by 2 × 20 minutes reactions with 2 ×
400 µl 10 mM TCEP in TBS 40% acetonitrile and the solid
support washed with 200 µl 40% acetonitrile in TBS. The
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solutions collected were combined and freeze-dried. The solid
was dissolved in 500 µl 20% acetonitrile and loaded on an
equilibrated 1 cc Oasis HLB cartridge (Waters) together with
500 µl 0.1% TFA. The column was washed with 3 × 1 mL 0.1%
TFA, 3 × 1 mL 5% acetonitrile 0.1% TFA and 1 × 1 mL 10%
acetonitrile 0.1% TFA. These extensive washes are required to
remove the TCEP from the cartridge. The conjugates are
released using 500 µl 60% acetonitrile and diluted with
500 µl 0.1% TFA. The resulting solution was freeze-dried and
dissolved in 500 µl water. The concentration was determined
and the solution was stored in the freezer for use in cellular
assays.
Splice-redirection assay
The splicing redirection assay was carried out similarly to a
previously reported procedure with minor changes.6 The
assay was performed using 48-well plates with cells seeded
the previous day (7.5 × 104 cells per well) and a total volume
100 μl per well for the conjugates’ solutions in OptiMEM.
Note that we found that 96-well plates tended to give too high
a scatter probably because of the smaller volumes in pipet-
ting. RT PCR experiments were carried out as reported in pre-
vious publications.12c All experiments were performed in
triplicates, unless specifically stated as designed one-point
experiments.
Conclusion
We have developed a novel rapid parallel synthesis method-
ology (SELPEPCON) for the synthesis of libraries of conjugates
of peptides with a PNA cargo and assayed the conjugates in a
splicing redirection assay in HeLa pLuc705 cells. Alkyne and
azide functional groups, which are known to be compatible
with the most commonly used bio-molecules, are readily intro-
duced on peptide and cargo moieties respectively. The methodo-
logy is capable of robotization and is applicable to large
libraries of peptide conjugates of biomolecules, such as oligo-
nucleotides and their analogues, peptides, siRNA etc., and in
amounts suitable for in vitro or cell screening. We expect the
SELPEPCON method to have wide applicability in drug
discovery.
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